Clinical trial
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
NCT00134901 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00134901 |
|---|---|
| Title | Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2 |
| Official title | A Double-Blind, Placebo-Controlled Trial of the Effectiveness of Memantine in Treating Cocaine Dependence |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH Research Foundation for Mental Hygiene, Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Memantine, placebo |
| Enrollment | 81 |
| Start date | Mar 1, 2003 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Aug 25, 2005 |
| Last update posted | Apr 24, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: